We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBE SCIENTIFIC, LLC

Co-Diagnostics, Inc.

Co-Diagnostics, Inc. is a molecular diagnostics company that develops, manufactures and markets a new, state-of-the-a... read more Featured Products: More products

Download Mobile App





Co-Diagnostics Introduces Co-Dx PCR Platform and Co-Primers Technology

By LabMedica International staff writers
Posted on 11 Nov 2024

Co-Diagnostics (Salt Lake City, UT, USA), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, is hosting a booth and delivering a presentation at the MEDICA 2024 trade fair in Düsseldorf. More...

MEDICA has become the world's largest medical B2B trade fair, attracting 83,000 visitors and over 5,300 exhibitors from almost 70 countries. The company aims to use the opportunity to generate increased interest in its suite of PCR in vitro diagnostic and research products for infectious diseases and to introduce and promote its Co-Primers technology and applications to a wide audience of international attendees.

Co-Primers by Co-Diagnostics is a new class of primer technology that uses a novel architecture to help combat some common issues that can plague multiplex PCR. The unique Co-Primers design reduces primer dimer propagation. Co-Primers technology includes the use of cooperative primers sometimes in combination with other types of primers or probe designs, and is the first PCR technology of its kind to help prevent primer dimer propagation during nucleic acid amplification. In multiplexed reactions where large numbers of primers increase the probability of primer dimer formation, enhanced specificity is particularly important. In a traditional primer process, a pair of primers hybridizes with the sample DNA or RNA sequence and defines the region that will be amplified. In a Co-Primers process, the PCR primer is divided into two segments separated by a PEG (polyethylene glycol) linker. Both the capture sequence and the priming sequence must cooperate to bind to the DNA or RNA target to amplify the intended region. Primer dimers are not propagated because they cannot hybridize to the capture region.

The company's presentation on its upcoming Co-Dx PCR platform is titled "Advancing POC/OTC Diagnostics: Innovations in Test Development for the Co-Dx PCR Platform". The Co-Dx PCR testing platform aims to provide accessible, affordable PCR testing for all, transforming healthcare delivery and creating a positive impact on a global scale by democratizing access to molecular diagnostics. The instrument with dimensions of 6 ½” x 4 1/2” x 6” and weighing two pounds operates via a smartphone app with simple-to-follow instructions that include videos to walk users through every step, some sample swab collection to the straightforward instrument operation. Results are processed in the cloud and delivered back to the user’s smartphone or tablet in about 30 minutes using software designed from the ground up for this specific use. The PCR tests themselves (contained in the simple but unique, innovative test collection cups) are powered by Co-Primers PCR technology.

Related Links:
Co-Diagnostics


Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Serological Pipet Controller
PIPETBOY GENIUS
New
Multilevel Whole Blood Calibrator Set
6PLUS1
New
Enterovirus Test
Quanty Enterovirus System
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Non-coding RNAs CBR3-AS1 and PCA3 can be utilized as therapeutic targets and prognostic biomarkers in gastric cancer (Photo courtesy of Adobe Stock)

Promising Molecular Markers Support Earlier Diagnosis of Gastric Cancer

Late detection continues to make gastric cancer one of the leading causes of cancer-related deaths globally. With improved early detection tools urgently needed, researchers have now identified two long... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The tip optofluidic immunoassay platform enables rapid, multiplexed antibody profiling using only 1 μL of fingertip blood (Photo courtesy of hLife, DOI:10.1016/j.hlife.2025.04.005)

POC Diagnostic Platform Performs Immune Analysis Using One Drop of Fingertip Blood

As new COVID-19 variants continue to emerge and individuals accumulate complex histories of vaccination and infection, there is an urgent need for diagnostic tools that can quickly and accurately assess... Read more

Pathology

view channel
Image: The new technology combines a rapid hemoglobin test with a smartphone app (Photo courtesy of 123RF)

Smartphone-Based Rapid Hemoglobin Test Accurately Detects Colorectal Cancer

Despite the availability of colorectal cancer screening programs, participation remains low, especially for fecal immunochemical tests (FIT), a non-invasive method to detect hidden blood in the stool.... Read more

Technology

view channel
Image: The machine learning-based method delivers near-perfect survival estimates for PAC patients (Photo courtesy of Shutterstock)

AI Method Predicts Overall Survival Rate of Prostate Cancer Patients

Prostate adenocarcinoma (PAC) accounts for 99% of prostate cancer diagnoses and is the second most common cancer in men globally after skin cancer. With more than 3.3 million men in the United States diagnosed... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.